Magnus Persson

Magnus Persson is a distinguished medical professional and entrepreneur with extensive experience in the life sciences sector. Currently serving as a Founding Partner at Eir Ventures since July 2020, Magnus also holds the position of Chairman of the Board at Cantargia AB, a public immune-oncology company. Previous roles include Chairman of the Board for several organizations such as Attgeno AB, ADDI Medical AB, Trailhead Biosystems Inc., and SLS Ventures, as well as serving as a Board Director for Cerecor Inc. and Gyros AB. Magnus’s background in medicine is supported by a dual MD, PhD in Physiology from Karolinska Institutet and Harvard Medical School, and practical experience as a Medical Doctor at Barnsjukhuset Martina.